Trial Profile
Liposomal cisplatin in cancer patients with renal failure.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Sep 2012
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Fluorouracil; Folinic acid; Gemcitabine; Paclitaxel
- Indications Bladder cancer; Gastrointestinal cancer; Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Regulon
- 11 Sep 2012 New trial record
- 15 Aug 2012 Results from this trial to be published in the Journal of Drug Delivery & Therapeutics, according to a Regulon media release.